Tuis2196 • HKG
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Vorige sluiting
$19,82
Dagwisseling
$19,83 - $20,54
Jaarwisseling
$12,78 - $29,00
Markkapitalisasie
77,34 mjd HKD
Gemiddelde volume
2,44 m
P/V-verhouding
14,17
Dividend-opbrengs
1,71%
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 12,27 mjd | 20,81% |
Bedryfskoste | 5,92 mjd | 39,11% |
Netto inkomste | 847,27 m | 11,59% |
Netto winsgrens | 6,91 | -7,62% |
Wins per aandeel | — | — |
EBITDA | 1,47 mjd | 45,62% |
Effektiewe belastingkoers | 6,50% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 15,36 mjd | -4,73% |
Totale bates | 120,05 mjd | 2,21% |
Totale aanspreeklikheid | 58,21 mjd | 1,19% |
Totale ekwiteit | 61,84 mjd | — |
Uitstaande aandele | 2,64 mjd | — |
Prys om te bespreek | 1,07 | — |
Opbrengs op bates | 1,47% | — |
Opbrengs op kapitaal | 1,78% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 847,27 m | 11,59% |
Kontant van bedrywe | 1,83 mjd | 22,89% |
Kontant van beleggings | -633,93 m | 45,98% |
Kontant van finansiering | 337,12 k | 100,07% |
Netto kontantverandering | 1,10 mjd | 1 382,17% |
Beskikbare kontantvloei | 5,59 mjd | 91,26% |
Meer oor
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Gestig
1994
Webwerf
Werknemers
40 603
